Medical Care
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Research Report 2025
- Jul 08, 25
- ID: 348029
- Pages: 62
- Figures: 69
- Views: 2
The global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors
North American market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors include F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc, Puma Biotechnology, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors.
The HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc
Novartis AG
Pfizer Inc
Puma Biotechnology, Inc
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors
North American market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors include F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc, Puma Biotechnology, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors.
The HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc
Novartis AG
Pfizer Inc
Puma Biotechnology, Inc
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Gastric Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Perspective (2020-2031)
2.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Trends by Region
2.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Region (2020-2025)
2.2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2026-2031)
2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Dynamics
2.3.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Trends
2.3.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
2.3.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
2.3.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue
3.1.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue (2020-2025)
3.1.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Players (2020-2025)
3.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue
3.4 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio
3.4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2024
3.5 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Head office and Area Served
3.6 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application
3.7 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Type
4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Type (2020-2025)
4.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2026-2031)
5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Application
5.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Application (2020-2025)
5.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
6.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
6.4 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
7.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
7.4 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
8.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025)
8.4 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
9.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
9.4 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
10.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
10.4 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.2.4 Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.2.5 Merck & Co., Inc Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.3.4 Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.3.5 Novartis AG Recent Development
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Details
11.4.2 Pfizer Inc Business Overview
11.4.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.4.4 Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.4.5 Pfizer Inc Recent Development
11.5 Puma Biotechnology, Inc
11.5.1 Puma Biotechnology, Inc Company Details
11.5.2 Puma Biotechnology, Inc Business Overview
11.5.3 Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.5.4 Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.5.5 Puma Biotechnology, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Gastric Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Perspective (2020-2031)
2.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Trends by Region
2.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Region (2020-2025)
2.2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2026-2031)
2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Dynamics
2.3.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Trends
2.3.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
2.3.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
2.3.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue
3.1.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue (2020-2025)
3.1.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Players (2020-2025)
3.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue
3.4 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio
3.4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2024
3.5 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Head office and Area Served
3.6 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application
3.7 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Type
4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Type (2020-2025)
4.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2026-2031)
5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Application
5.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Application (2020-2025)
5.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
6.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
6.4 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
7.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
7.4 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
8.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025)
8.4 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
9.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
9.4 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)
10.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)
10.4 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.2.4 Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.2.5 Merck & Co., Inc Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.3.4 Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.3.5 Novartis AG Recent Development
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Details
11.4.2 Pfizer Inc Business Overview
11.4.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.4.4 Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.4.5 Pfizer Inc Recent Development
11.5 Puma Biotechnology, Inc
11.5.1 Puma Biotechnology, Inc Company Details
11.5.2 Puma Biotechnology, Inc Business Overview
11.5.3 Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.5.4 Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
11.5.5 Puma Biotechnology, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2020-2025)
Table 8. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2026-2031)
Table 10. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends
Table 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
Table 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
Table 13. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints
Table 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players (2020-2025)
Table 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2024)
Table 17. Ranking of Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Headquarters and Area Served
Table 20. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application
Table 21. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2020-2025)
Table 25. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2026-2031)
Table 27. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2020-2025)
Table 29. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2026-2031)
Table 31. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd Company Details
Table 47. F. Hoffmann-La Roche Ltd Business Overview
Table 48. F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 49. F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd Recent Development
Table 51. Merck & Co., Inc Company Details
Table 52. Merck & Co., Inc Business Overview
Table 53. Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 54. Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 55. Merck & Co., Inc Recent Development
Table 56. Novartis AG Company Details
Table 57. Novartis AG Business Overview
Table 58. Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 59. Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Pfizer Inc Company Details
Table 62. Pfizer Inc Business Overview
Table 63. Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 64. Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 65. Pfizer Inc Recent Development
Table 66. Puma Biotechnology, Inc Company Details
Table 67. Puma Biotechnology, Inc Business Overview
Table 68. Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 69. Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 70. Puma Biotechnology, Inc Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report
List of Figures
Figure 1. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Picture
Figure 2. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type: 2024 VS 2031
Figure 4. Monotherapy Features
Figure 5. Combination Therapy Features
Figure 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2024 VS 2031
Figure 8. Breast Cancer Case Studies
Figure 9. Gastric Cancer Case Studies
Figure 10. Ovarian Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Report Years Considered
Figure 13. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region: 2024 VS 2031
Figure 16. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players in 2024
Figure 17. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2024
Figure 19. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 21. United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 25. Germany HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2020-2031)
Figure 33. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 41. Mexico HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 45. Turkey HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 49. Merck & Co., Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 51. Pfizer Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 52. Puma Biotechnology, Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2020-2025)
Table 8. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2026-2031)
Table 10. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends
Table 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
Table 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
Table 13. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints
Table 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players (2020-2025)
Table 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2024)
Table 17. Ranking of Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Headquarters and Area Served
Table 20. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application
Table 21. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2020-2025)
Table 25. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2026-2031)
Table 27. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2020-2025)
Table 29. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2026-2031)
Table 31. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd Company Details
Table 47. F. Hoffmann-La Roche Ltd Business Overview
Table 48. F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 49. F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd Recent Development
Table 51. Merck & Co., Inc Company Details
Table 52. Merck & Co., Inc Business Overview
Table 53. Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 54. Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 55. Merck & Co., Inc Recent Development
Table 56. Novartis AG Company Details
Table 57. Novartis AG Business Overview
Table 58. Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 59. Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Pfizer Inc Company Details
Table 62. Pfizer Inc Business Overview
Table 63. Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 64. Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 65. Pfizer Inc Recent Development
Table 66. Puma Biotechnology, Inc Company Details
Table 67. Puma Biotechnology, Inc Business Overview
Table 68. Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 69. Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)
Table 70. Puma Biotechnology, Inc Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report
List of Figures
Figure 1. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Picture
Figure 2. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type: 2024 VS 2031
Figure 4. Monotherapy Features
Figure 5. Combination Therapy Features
Figure 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2024 VS 2031
Figure 8. Breast Cancer Case Studies
Figure 9. Gastric Cancer Case Studies
Figure 10. Ovarian Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Report Years Considered
Figure 13. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region: 2024 VS 2031
Figure 16. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players in 2024
Figure 17. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2024
Figure 19. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 21. United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 25. Germany HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2020-2031)
Figure 33. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 41. Mexico HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)
Figure 45. Turkey HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 49. Merck & Co., Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 51. Pfizer Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 52. Puma Biotechnology, Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232